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Redundant and Alternative Roles for Activating Fc
Receptors and Complement in an Antibody-Dependent
Model of Autoimmune Vitiligo
Grave’s hyperthyroidism. Furthermore, experimental
models of autoimmune disease have emphasized a cru-
cial role for FcR in the pathogenesis of these inflamma-
tory diseases (Ravetch and Clynes, 1998). Vitiligo is a
prevalent and often disfiguring disease of acquired hy-
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and Alan N. Houghton1,5 popigmentation that is due to destruction of cutaneous
melanocytes (Nordlund and Ortonne, 1998). Melano-1The Swim Across America Laboratory
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somes, which are specialized vesicles found in the endo-Weill Graduate School of Cornell University
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1998). In support of this notion, autoantibodies specificHarvard Medical School
Boston, Massachusetts 02115 for melanosome membrane glycoproteins are found in
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Passive or active immunization against the melano-Summary
some antigen TYRP-1 induces antibody-dependent hy-
popigmentation in mice (including C57BL/6, DBA/2, SJL,Complement and Fc receptor (FcR)-positive cells me-
diate effector functions of antibodies. Antibody-depen- and C3H/HeN strains), showing that autoantibodies are
sufficient to elicit vitiligo in otherwise healthy hosts (Haradent immunity against the melanosome membrane
glycoprotein gp75/tyrosinase-related protein-1 (TYRP-1) et al., 1995; Clynes et al., 1998; Overwijk et al., 1999;
A.N.H, unpublished data). In other experimental modelsof melanocytes leads to autoimmune hypopigmenta-
tion (vitiligo) in mice. Hypopigmentation occurred in of antibody-dependent autoimmune diseases, FcR have
been directly implicated in disease pathogenesis. Acti-mice deficient in activating FcR containing the com-
mon  subunit (FcR /) and in mice deficient in the vating FcR containing common  chain, particularly the
IgG low affinity activation receptor FcRIII, is necessaryC3 complement component. Mice doubly deficient in
both FcRand C3 did not develop hypopigmentation, in mouse models of autoimmune hemolytic anemia and
thrombocytopenia, glomerulonephritis, collagen-inducedsuggesting that complement and FcR formed redun-
dant mechanisms. Following passive immunization arthritis, alveolitis, and Goodpasture’s disease (discussed
in Clynes and Ravetch, 1995). Specifically, mice deficientwith antibody, no further adaptive immune responses
were required. Chimeric FcR /,C3/ mice recon- in FcR  chain are protected in these autoimmune mod-
els, and absence of inhibitory Fc receptors (FcRIIB) canstituted with bone marrow from either FcR / or
C3/ mice or adoptively transferred with FcR / accelerate disease (Yuasa et al., 1999; Nakamura et al.,
2000). However, in autoimmune models of vitiligo wheremacrophages did develop antibody-mediated hypo-
pigmentation. Thus, either complement or macro- C57BL/6 mice are actively or passively immunized against
TYRP-1, preliminary studies have suggested that anti-phages expressing activating FcR can independently
and alternatively mediate disease in a model of auto- body-dependent autoimmunity after induction of either
active or passive immunity surprisingly proceeds in theimmune vitiligo.
absence of FcR  chain (Clynes et al., 1998; Weber
et al., 1998). Here we show that activating FcR onIntroduction
macrophages is actually involved in the pathogenesis
of experimental vitiligo but that the complement systemMany autoimmune diseases are characterized by the
presence of autoantibodies. The detection of autoanti- provides an alternative pathway.
bodies can be required for a diagnosis of autoimmune
diseases, and titer can reflect the severity of disease. Results
Autoantibodies have been directly implicated in the
pathogenesis of disease, e.g., autoimmune hemolytic Antibody-Induced Hypopigmentation
anemia and thrombocytopenia, myasthenia gravis, and Antibody-dependent hypopigmentation in mice is in-
duced after both active and passive immunization
against the melanocyte glycoprotein TYRP-1 (Hara et5 Correspondence: a-houghton@ski.mskcc.org
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Table 2. Hypopigmentation in Mice Passively Immunized againstTable 1. Hypopigmentation in Mice Passively Immunized against
TYRP-1 TYRP-1
Mouse Strain # Hypopigmented Mice/Totala # Hypopigmented
Mouse Strain Treatment Mice/Totala
RAG-1/ 3/3
FcR / 15/15 Wt C57BL/6 None 20/20
UVB irradiatedb 6/6CD4/ 5/5
Ig/ 3/3 anti-TNF- mAbc 5/5
UVB  anti-TNF- 2/2CR1/CR2 5/5
TcR/ 3/3 gld/gldC57BL/6 None 7/7
anti-TNF- 4/4FcR /, FcRII/ 3/3
FcRII/ 2/2
a Mice were passively immunized with mAb TA99 as described in
Experimental Procedures.a Mice were depilated on day 0 and passively immunized with mouse
mAb TA99 as described in Experimental Procedures. No vitiligo b Mice were UVB irradiated with 2000 J/m on day 0.
c Mice were treated with anti-TNF- mAb 2 hr before each TA99developed in control C57BL/6 mice passively immunized with iso-
type-matched mAb UPC10 (0/18 C57BL/6 mice). injection.
ing death of epidermal Langerhans cells as well as in-Overwijk et al., 1999). In most mouse strains, including
traepithelial dendritic T cells, did develop hypopigmen-C57BL/6 mice, melanocytes are present in hair bulbs,
tation (Table 2) (Tigelaar and Lewis, 1995).and hypopigmentation manifests by profound dilution
It was possible that autoantibodies against TYRP-1of coat color, particularly in regenerating hairs. The mAb
induced melanocyte death either directly or indirectlyTA99 is a mouse IgG2a autoantibody that reacts with
by triggering cell death pathways. We had previouslyTYRP-1 expressed by mouse melanocytes (Thomson et
shown that mAb TA99 does not induce any detectableal., 1988; Vijayasaradhi et al., 1990; Hara et al., 1995).
target cell death or alteration in survival of cultured mela-Antibody-dependent hypopigmentation was evaluated
nocytes (Takechi et al., 1996). Because transformed mel-at depilated coat sites in regenerating hairs after passive
anocytes can express fas (Hahne et al., 1996), a role forimmunization. In initial experiments, mice deficient in
the fas-fas ligand (fasL) system in antibody-dependentFcR  chain were able to develop hypopigmentation
immunity was examined. gld/gld mice developed hypo-after passive immunization against TYRP-1 (Table 1), a
pigmentation, ruling out a role for fasL (Table 2). In addi-phenomenon that we have also observed after active
tion, systemic injection of neutralizing antibody againstinduction of autoimmunity against TYRP-1 in FcR 
TNF-, which is produced by keratinocytes and dermalchain-deficient mice (Clynes et al., 1998; Weber et al.,
infiltrating macrophages (Kock et al., 1990), did not1998). In addition, mice deficient in FcRII and doubly
block hypopigmentation even in gld/gld mice or in com-deficient in both FcR  chain and FcRII developed
bination with UVB irradiation (Table 2). Normal cutane-hypopigmentation. Hypopigmentation was not notice-
ous melanocytes are protected against programmedably more severe in mice lacking inhibitory FcRII recep-
cell death in part through expression of bcl-2, so thistors, and in all these deficient strains the severity of
result was not unexpected (Nakayama et al., 1994).hypopigmentation was similar to that reported pre-
viously in wild-type C57BL/6 mice after either passive
or active immunization against TYRP-1 (Table 1) (Hara Antibody-Dependent Hypopigmentation Mediated
through Either FcR or Complementet al., 1995; Clynes et al., 1998; Weber et al., 1998).
Thus, activating FcR or combinations of activating and Because FcR were not required for autoimmune hypo-
pigmentation, an alternative simple explanation was thatinhibitory FcR were not required for induction of disease.
Because autoimmune hypopigmentation can occur complement activation was necessary, although this
would go against the large body of experimental evi-independently of FcR, it was possible that antibody or
antibody-antigen complexes might have recruited fur- dence for a primary role of FcR in antibody-dependent
autoimmune diseases. However, C3/ mice still devel-ther adaptive immune responses downstream, e.g., elic-
itation of T cell responses through processing and pre- oped hypopigmentation after passive immunization (Ta-
ble 3). Mice deficient for complement receptor 1 andsentation of antibody-antigen immune complexes or by
induction of anti-idiotype responses. Experiments 2 also developed hypopigmentation (Table 1). These
results are consistent with a mechanism that is indepen-showed that no further involvement of adaptive immu-
nity was necessary (Tables 1 and 2) because, first, nei- dent of complement and these complement receptors.
Another explanation was that hypopigmentation wasther T cells nor B cells were required for downstream
mechanisms. RAG-1/, CD4/, TcR/ mice (ex- mediated through two distinct and alternative pathways
involving either activating FcR or complement. Three dif-pressed by intraepithelial dendritic T cells) (Tigelaar and
Lewis, 1995), and Ig/and CR1/CR2/mice (deficient ferent types of experiments supported this scenario. In
the first experiments, double-deficient FcR /,C3/in antibody responses to T cell-dependent antigens
[Molina et al., 1996]) developed hypopigmentation (Ta- mice were passively immunized against TYRP-1. Hypo-
pigmentation could not be induced in these mice (Tableble 1). Second, Langerhans cells in the epidermis were
not implicated in uptake and presentation of antigen 3 and Figure 1). This finding suggested that autoimmune
vitiligo was established either through FcR positiveor antibody-antigen complexes because C57BL/6 mice
exposed to ultraviolet B wavelength (UVB) radiation, cells or the complement system.
Second, when FcR /,C3/ mice were injectedwhich is known to impair cutaneous immunity by induc-
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the other hand, donor marrow from C3/ mice led toTable 3. Lack of Hypopigmentation in Mice Deficient in Both FcR
 and C3 and Hypopigmentation following Bone Marrow reconstitution of FcR chain expression by hematopoi-
Reconstitution etic cells, determined on mast cells and NK cells. Wild-
type mast cells and NK cells normally express FcRIRecipient/Treated # Hypopigmented
and FcRIII, respectively. However, in FcR / miceDonor Group Mice/Total
neither receptor is expressed on these cell types. BoneNone C3/ 3/3
marrow chimerism was predominantly donor origin inNone FcR /, C3/ 0/8
FcR /,C3/ mice receiving C3/ donor marrow. ANone FcR /  TA99  Ca 3/3
None FcR /  TA99b 0/3 mean of 80% (range 65%–96%) of bone marrow-derived
FcR /,C3/ FcR /,C3/ 0/3 mast cells obtained from mice reconstituted with C3/
FcR / FcR /,C3/ 3/3 (FcR /) bone marrow were positive for FcRI, and
C3/ FcR /,C3/ 3/3
no expression of FcRI (	1%) was seen on mast cells
Mice were passively immunized with mAb TA99 as described in obtained from recipients of either FcR / or FcR
Experimental Procedures. /,C3/ bone marrow. Similarly, peripheral blood
a Mice were passively immunized with mAb TA99 subcutaneously NK1.1 cells and IL-2-stimulated NK1.1 splenocytes
with sera from healthy C57BL/6 mice as a source of complement.
were positive for FcRIII expression isolated from chime-b Mice were passively immunized with mAb TA99 subcutaneously,
ric mice reconstituted with C3/ marrow (67% FcRIIIbut mouse serum was heated to 56
C for 30 min to inactivate com-
plement. versus 71% FcRIII from wild-type C57BL/6 mice) but
not with FcR / or FcR /,C3/ bone marrow
(	1.5% FcRIII). Thus, bone marrow reconstitution was
able to generate either complement or FcR -chaincutaneously and subcutaneously with mAb TA99 plus
positive cells in recipient mice.normal C57BL/6 mouse serum as a source of comple-
Mice that were reconstituted with either FcR cellsment, local hypopigmentation at the injected site was
(after transplant with C3/ marrow) or with C3 (afterobserved, but not when the mouse serum was heated
receiving FcR/ marrow) developed hypopigmenta-to 56
C for 30 min to inactivate complement (Table 3),
tion after passive immunization (Table 3 and Figure 1).suggesting that complement was sufficient to induce
However, mice receiving marrow from FcR /,C3/autoimmunity in the absence of endogenous comple-
donors showed no signs of hypopigmentation (Table 3ment and activating FcR. These results showed that
and Figure 1). Thus, these independent lines of evidenceFcR /,C3/ mice were competent to develop hypo-
establish that autoimmunity is mediated either throughpigmentation.
activating FcR or complement.In a third set of experiments, either FcR or comple-
ment was shown to provide alternative pathways by
transplanting bone marrow from mice genetically defi- Macrophages Expressing FcR Mediate
Antibody-Dependent Vitiligocient in either FcR  chain or C3 complement compo-
nent into lethally irradiated FcR /,C3/ recipients. To address which bone marrow-derived cell type medi-
ates vitiligo in this model, histologic sections of skinMice reconstituted with bone marrow from FcR /
donors developed detectable serum C3 levels: levels were examined. Mononuclear cell infiltrates were sub-
stantially increased in the dermis around hair follicles inwere 605  136 g/ml (mean  range) compared to
872  164 g/ml in wild-type C57BL/6 mice. Levels in mice passively immunized against TYRP1 compared to
mice receiving isotype-matched mAb (Figures 2A andFcR /,C3/ and C3/ mice were 	3 g/ml. On
Figure 1. Hypopigmentation Not Present in
FcR /,C3/ Mice Passively Immunized
with TA99 mAb against TYRP-1 and Rescued
with Bone Marrow Reconstitution
(A) FcR /,C3/ mice did not develop hy-
popigmentation.
(B) FcR /,C3/ recipients transplanted
with bone marrow from FcR /,C3/ do-
nors showed no hypopigmentation after im-
munization.
(C) FcR /,C3/ recipients transplanted
with bone marrow from C3/ donors.
(D) FcR /,C3/ recipients transplanted
with bone marrow from FcR / donors.
All mice were depilated over the posterior
trunk where hypopigmentation is most promi-
nent (see [C] and [D]), but when hypopigmen-
tation occurred, it also spread outside the
original depilated areas.
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Figure 2. Histology of Epidermis and Dermis,
Including Hair Follicles, of C57BL/6 Mice Pas-
sively Immunized with Either TA99 mAb against
TYRP1 or Isotype-Matched mAb UPC10
Histologic sections are from mice passively
immunized intraperitoneally with antibody ev-
ery 2–3 days for five injections. Skin biopsies
were obtained 3 days after the last antibody
injection. (A) shows epidermis and dermis
from mice receiving control mAb UPC10. His-
tology reveals minimal background mononu-
clear inflammatory cells in the dermis. (B), in
contrast, shows a much more extensive mono-
nuclear dermal infiltrate distributed about the
hair follicle (where melanocytes are located
in the mouse). (C) and (D) demonstrate the
phenotype of inflammatory cells by immuno-
stain with isotype-matched control mAb (C)
or mAb against Mac-3 (D). Note the abun-
dance of cells staining positively (brown) for
Mac-3 distributed about the hair follicles. (E)
shows staining of the cells for nonspecific
esterase activity (magenta stain), confirming
the macrophage identity of these mononu-
clear cells about the hair follicle. (F) shows
that infiltrating cells do not express CD3.
Magnification 40. Sections are counter-
stained with hematoxylin.
2B). The mononuclear cell infiltrates were largely com- ligo-resistant FcR/,C3/ recipients in the presence
of TA99 mAb or isotype-matched control mAb. Vitiligoposed of cells with macrophage morphologies, inter-
spersed with rare lymphoid cells. Phenotypic character- was induced in an FcR-dependent manner in TA99-
treated mice. TA99-treated mice exhibited vitiligo afterization showed that almost all infiltrating cells were Mac-
3 by antibody staining and were positive for esterase transfer of FcR/ macrophages, but no vitiligo was
observed in mice receiving FcR/ macrophages (Ta-activity (Leder, 1964) (Figures 2D and 2E) with the re-
maining rare infiltrating cells staining for CD3 (Figure ble 4). The same incidence of vitiligo was observed in
TA99-treated FcR/,C3/ positive control mice2F). Measurements of the inflammatory cytokines IL-
1, TNF-, and MCP-1 in the skin of mice passively without adoptive transfer of cells. Thus, FcR-bearing
macrophages were necessary to mediate vitiligo in vivo,immunized with TA99 mAb were elevated but were not
any different from control mice receiving isotype- showing that these cells can mediate autoimmune viti-
ligo in this model.matched control antibody (data not shown).
Adoptive transfer experiments were performed to
confirm that macrophages expressing FcR receptors Discussion
were necessary for antibody-dependent vitiligo. To re-
constitute the effector response, 2  105 FcR / A direct pathogenic role for immunity against melano-
some glycoproteins has been shown in experimentalor / bone marrow-derived macrophages from C3/
background mice were injected subcutaneously into viti- mouse models of hypopigmentation (Hara et al., 1995;
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Table 4. Requirement for FcR  Macrophages in Vitiligo Follows Adoptive Transfer
FcR/,C3/ Recipients of
Bone Marrow-Derived MacrophagesTreated Mice FcR /,C3/ Mice FcR /,C3/ Mice
Adoptive Transfer No transfer No transfer FcR / Macrophages FcR / Macrophages
TA99 mAba 2/3 0/3 0/3 2/3
Control mAba 0/3 0/3 0/3 0/3
a Groups of mice were passively immunized with TA99 mAb against TYRP-1 or isotype-matched IgG2a mouse mAb subcutaneously with or
without adoptive transfer of macrophages as described in Experimental Procedures. Number of mice with hypopigmentation/total # mice
treated.
Naftzger et al., 1996; Weber et al., 1998; Clynes et al., al., 1997; Kohl and Gessner, 1999; Heller et al., 1999;
Baumann et al., 2000). Early complement components,1998; Bowne et al., 1999; Overwijk et al., 1999). The
mouse models develop hypopigmentation of coat color, like C3, are presumably not generally involved in the
Arthus reaction, either in skin, lung, kidney, or synovium.histologically characterized by loss of melanocytes in
hair follicles and sparse leukocyte infiltrates (Hara et al., In contrast, late components, like C5a, appear to be
involved in synovium and perhaps other sites. In any1995; Weber et al., 1998; Overwijk et al., 1999). Cutane-
ous melanocytes in most mouse strains are restricted case, our results show that these divergent pathways,
FcR and complement, can clearly play a redundant roleto hair follicles. However, in studies of transgenic mice
that have epidermal melanocytes (which more directly in an autoimmune model.
An identical phenotype of hypopigmentation can bereflects the physiology of melanocytes in human skin)
(Kunisada et al., 1998), autoimmune cutaneous hypopig- also induced through CD8 T cell-dependent pathways
that require perforin but are independent of antibodymentation has both clinical and histologic characteris-
tics that directly mimic vitiligo in humans (J.T., J. (Bowne et al., 1999). This means that the pathogenesis
of hypopigmentation can proceed through at least threeLongeley, E. Carter, and A.N.H., unpublished data).
We describe mechanisms underlying a tissue-specific pathways: (1) antibody-dependent mechanisms involv-
ing activating FcR, (2) antibody-dependent pathwaysautoimmunity mediated by antibodies. Our results dem-
onstrate that antibody-mediated responses, specifically using complement, or (3) cytotoxic T cells (and antibody-
independent events). The mechanism of vitiligo in thesemediated by IgG2a antibodies, can proceed through
pathways that use either FcR or complement. FcR- models is dependent on the antigen used to induce
autoimmunity. Immunity against TYRP-1 is mediated byindependent mechanisms must underlie vitiligo induced
by both passive and active immunization (Weber et al., autoantibodies, but immunity against the closely related
paralogue TRP-2 is dependent on cytotoxic T cells (We-1998). The FcR-dependent mechanism of vitiligo in-
volves tissue macrophages. Evidence for involvement ber et al., 1998; Bowne et al., 1999). These two antigens
are closely related at the amino acid sequence level,of FcR-positive macrophages is also compelling for
immunity against melanoma, which is transformed mela- and their expression is restricted to the same subcellular
site in melanocytes. Thus, the immunogenic propertiesnocytes (Clynes et al., 2000). One possibility is that both
FcR and complement-mediated pathways recruit mac- of closely related molecules can trigger quite distinct
pathways leading to the same type of autoimmune dis-rophages as final effector cells, perhaps through CR3
for complement. ease. The major difference between these two mole-
cules is small variations in amino acid sequenceIt has been proposed that FcR and complement sys-
tems evolved independently for different purposes (Ra- throughout the molecules. These small variations must
be sufficient to initiate qualitatively very different mecha-vetch and Clynes, 1998). FcRs participate in initiating
inflammatory autoimmunity, and complement is impor- nisms of autoimmune vitiligo. These distinct functional
pathways can also form redundant mechanisms for au-tant for innate immune responses such as against bacte-
rial pathogens and toxins. Our results showed that both toimmune vitiligo in the case of antibody-dependent
mechanisms. Blockade of both activating FcR andpathways can independently mediate a cutaneous auto-
immune reaction. Potentially additive and codominant complement (which proceed independently of cytotoxic
T cells) or cytotoxic T cell responses (which proceedroles for FcR and the C5a component of complement
previously have been suggested for Arthus reactions independently of antibody) will be required to overcome
experimental autoimmune vitiligo.triggered by immune complexes of foreign antigen (i.e.,
rabbit anti-ovalbumin/ovalbumin), depending on the tis-
Experimental Proceduressue site of inflammation (Hazenbos et al., 1996; Kohl
and Gessner, 1999; Baumann et al., 2000). Cutaneous
Mice and Cells
Arthus reactions elicited by immune complexes with C57BL/6, C57BL/6gld/gld, CD4/ (Rahemtulla et al., 1991), TcR/
foreign antigen using rabbit antisera are largely depen- (Itohara et al., 1993), Ig/ (Kitamura et al., 1991), and RAG-1/
(Mombaerts et al., 1992) mice were obtained from Jackson Labora-dent on FcR (varying with the mouse strain and base-
tory (Bar Harbor, ME); these genetically deficient mice were all online levels of complement), but inflammation triggered
a C57BL/6 background. Black coat-colored complement receptorby immune complexes in the lung and peritoneum can
CR1/CR2/ (Molina et al., 1996) and C3/ mice (Wessels et al.,be dependent on both FcR and complement (Hazenbos
1995) were from a C57BL/6 x C57BL/6/129 background. FcR -
et al., 1996; Baumann et al., 2000; Sylvestre et al., 1996). deficient (Takai et al., 1994) and FcRII-deficient (Takai et al., 1996)
In particular, the complement component C5a is impli- mice have been described and were housed at Taconic Farms (Ger-
mantown, NY). FcR -deficient and FcRII-deficient mice had beencated through binding to the C5a receptor (Hopken et
Immunity
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crossed for twelve generations and nine generations, respectively, centage of NK1.1 cells which were also positive for FcRIII. Chime-
rism was confirmed by the percentage of c-kit positive mast cellsto a C57BL/6 background. Double-deficient FcR /,C3/ mice
resulted from the cross of these twelfth generation FcR / back- which were also positive for FcRI by IgE staining.
crossed mice with C3/ mice from a C57BL/6 x C57BL/6/129 back-
ground. Double-deficient FcR /, FcRII/ mice were generated Macrophage Adoptive Transfer Experiments
by crossing fourth generation backcrossed FcRII/ and eighth gen- Bone marrow-derived macrophages were obtained by growth of
eration backcrossed FcR / C57BL/6 mice. Six- to eight-week- nucleated bone marrow cells in 10% L929 conditioned media. In
old mice were used for experiments. brief, bone marrows were flushed with a 25 gauge needle in RPMI
medium, RBCs were lysed, and cells were cultured at 5  105 /ml
in DMEM/glutamine/10% FBS and 10% L929 conditioned media.Induction of Hypopigmentation with TA99 mAb
Adherent cells were harvested at day 6 of culture with ice-cold PBS/TA99 is a mouse IgG2a mAb specific for human and mouse TYRP-1
5mM EDTA. These cells were uniformly 99% positive for expres-(Vijayasaradhi et al., 1990; Hara et al., 1995). TA99 was purified by
sion of Mac-1 by flow cytometry (clone M1/70, Pharmingen). Afterprotein G affinity chromatography (Pharmacia, Uppsala, Sweden).
extensive washing in PBS, macrophages were resuspended atMice were mechanically depilated over an1 cm2 area at the center
106 cells/ml. Mice were depilated immediately prior to intradermalof the posterior flank under methoxyflurane anesthesia on day 0
injection of 200g TA99 and were subsequently injected subcutane-and received intraperitoneal injections with 0.3 mg of TA99 or of
ously with 200 l of macrophages (2  105 cells/mouse). Evidencethe isotype-matched control mAb UPC10 (Sigma) on days 0, 2, 4,
of depigmentation was observed as early as 3–4 weeks later upon7, 9, and 11. This dose of TA99 is 5-fold higher than the minimal
hair regrowth but was definitively scored at 10 weeks after injection.dose required for inducing hypopigmentation (Hara et al., 1995);
this dose was selected because it reproducibly induces prominent
hypopigmentation (50 of 50 C57BL/6 mice treated). Hypopigmen- Genotype Analysis
tation was scored when80% of regrowing hairs in depilated areas Genotypes of all transplanted mice were confirmed by PCR analysis
were white, but in control groups regrowth of depigmented hairs was of tail-tip DNA both before and after transplant using FcR  primers
always 	1%. Irradiation with bone marrow transplantation could and conditions as described (Clynes et al., 1998). For C3 PCR analy-
induce scattered white hairs in a salt and pepper pattern but never sis, the following primers were used: C3 5( 5-CTTCATAGACTGC
was5% of hairs. In some experiments, mice were subcutaneously/ TGCAACCA-3), C3 3(5-AACCAGCTCTGTGGGAAGTG-3), and
cutaneously injected once with 0.3 mg of TA99 or UPC10, with or neo-5 (AAGCCGGTCTTGTCGATCAG). Annealing temperature was
without 0.1–0.3 ml of normal mouse serum, at a depilated site. 56
C. Expected products were 950 bp for the wild-type and 900 bp
Injection of up to 1 mg of mAb UPC10 by either intraperitoneal or for the disrupted allele.
subcutaneous routes did not induce specific hypopigmentation.
Histologic Analysis
Immune Manipulation of Mice For identification of cell infiltrates, purified rat anti-mouse Mac-3
For ultraviolet B (UVB) irradiation, mice were depilated over an 1 (clone M3/84, BD Pharmingen) at a concentration of 1g/ml served
cm2 area at the center of flank, then irradiated with an UV irradiator as primary antibody. As the isotype control for Mac-3, purified rat
(Stratagene, La Jolla, CA) at a peak wavelength of 312 nm at 2000 IgG1 immunoglobulin isotype control (R3-34, BD Pharmingen) was
J/m2 on day 0. This dose of UVB irradiation induces disappearance employed. Whole goat serum was used as the blocking serum, and
of epidermal Langerhans cells at irradiated sites for 14 days (Odling biotinylated mouse anti-rat IgG1/2a antibody, multiple absorbed (BD
et al., 1987). For neutralization of TNF-, mice were injected intraper- Pharmingen), was used as secondary antibody. As an additional
itoneally with 250 g of neutralizing anti-TNF- mAb 2E2 (Hernan- means of macrophage identification, Leder’s esterase method was
dez-Caselles and Stutman, 1993) 2 hr before each TA99 mAb in- utilized (Leder, 1964). To identify T cells, rabbit anti-human T cell
jection. CD3 (Dako Corp., Carpinteria, CA) at a 5g/ml concentration was
used, and rabbit immunoglobulin fraction (X0903, Dako) was used
as the isotype control. With this primary antibody, whole goat serumBone Marrow Chimera
(ICN Biomedicals, Aurora, OH) was utilized as the blocking serumFcR /,C3/ mice received whole body  irradiation of 100 cGy.
and biotinylated anti-rabbit IgG made in goat (Vector Laboratories,Six to nine hours later, irradiated mice were injected intravenously
Burlingame, CA) at a 3 g/ml concentration as the secondary an-with 5  106 bone marrow cells from FcR /,C3/, FcR /,
tibody.or C3/ mice. Before injection, transplanted bone marrow cells
The avidin-biotin peroxidase method was used for immunohisto-were depleted of CD4 and CD8 cells with anti-CD4 mAb GK1.5
chemistry. Sections cut at 4 m were heated at 55
C overnight andfrom the American Type Culture Collection (ATCC, Gaithersburg,
then deparaffinized and quenched with 3% hydrogen peroxide toMD) and anti-CD8 mAb, 2.43 (ATCC) in the presence of rabbit com-
block endogenous peroxidase activity. Sections were immersed inplement. Six weeks after bone marrow transplantation, TA99 treat-
0.01 M citric acid buffer (pH 6) in a microwave oven for 5 min. Eachment was started, concomitant with depilation. Serum C3 comple-
section was incubated for 30 min with 10% goat serum. Primaryment levels were measured 18 weeks after transplant by ELISA as
antibodies were applied and incubated at 4
C overnight. After exten-described (Fischer et al., 1996).
sive washing, sections were incubated at room temperature withExpression of FcR in bone marrow chimeras was assessed in
the appropriate secondary antibody for 30 min. The sections againboth primary mast cells and NK cells. For mast cell isolation, bone
were thoroughly washed and then incubated with avidin-biotin per-marrow cells were cultured at 5  105 cells in 10% conditioned
oxidase complexes (Vector Laboratories). Diaminobenzidine liquidmedia of WEHI-3 cells (obtained from the ATCC, Gaithersburg, MD)
chromogen 0.1% (Dako) was used as the final chromogen. Slidesas a source of IL-3. After 6 weeks, all mast cell cultures were uni-
were counterstained with hematoxylin. For measurement of inflam-formly positive for the mast cell marker c-kit by FACS analysis
matory cytokines in skin, skin biopsies were snap frozen in liquid(Pharmingen clone ACK45; BD Pharmingen, La Jolla, CA). High affin-
nitrogen and homogenized. ELISAs for IL-1, TNF-, and MCP-1ity FcRI expression on mast cells was assessed by staining with
were performed according to the manufacturer’s instructions (Endo-mouse IgE followed by a secondary FITC-anti-mouse IgE (Phar-
gen Inc., Woburn, MA).mingen clone R35-72). NK cells, which normally express only FcRIII
but not FcRI or FcRII, were obtained from both peripheral blood
cells and 10 day cultures of IL-2-stimulated splenocytes (obtained Acknowledgments
as described in Takai et al., 1994)). In brief, nylon-wool nonadherent
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